- integratedbiotherapeuticvaccines.com
- 1
- 10
Prior vaccines developed for S. aureus, which were composed of surface antigens, failed clinically. At IBV, we are taking a different, more promising approach, and have developed IBT-V02, the first entirely toxoid-based vaccine designed to protect..
Relevance: 12.654132